TITLE

Atorvastatin reduced coronary and stroke events in patients with hypertension and without dyslipidemia

PUB. DATE
November 2003
SOURCE
ACP Journal Club;Nov/Dec2003, Vol. 139 Issue 3, p57
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
This article discusses efficacy of atorvastatin for primary prevention of coronary heart disease (CHD) in patients with hypertension and no dyslipidemia. Primary outcome was the combined endpoint of nonfatal myocardial infarcation (MI) and fatal CHD. Secondary endpoints were the primary outcome without silent events, total cardiovascular (CV) events, total coronary events, all-cause mortality, total CV mortality, fatal and nonfatal stroke and fatal and nonfatal heart failure. In patients with hypertension and other cardiovascular risk factors and without dyslipidemia, atorvastatin reduced coronary and stroke events at a median followup of 3.3 years.
ACCESSION #
11533482

 

Related Articles

  • COMMENTARY: Recalibration of the Framingham functions to the Chinese population improved coronary heart disease risk estimates. Fodor, J. George // ACP Journal Club;Nov/Dec2004, Vol. 141 Issue 3, p81 

    The article presents a commentary on the study, which concluded that recalibration of the Framingham functions to the Chinese population improved coronary heart disease (CHD) risk estimates. The Framingham risk function is the gold standard of global CHD risk evaluation. During the past decade,...

  • Cardiovascular highlights from non-cardiology journals. O'Flaherty, Martin; Huffman, Mark D.; Capewell, Simon // Heart;Sep2015, Vol. 101 Issue 17, p1433 

    The article focuses on a study on decreasing mortality rates of acute myocardial infarction (AMI) and coronary heart disease (CHD). Topics discussed include a decrease in mortality rates shown by multinational monitoring of trends and determinants in cardiovascular disease (MONICA) project...

  • The Direction of Information between Cardiorespiratory Hemodynamic Signals: Test Analysis using Granger Causality. Ghouali, Samir; Feham, Mohammed; Ghouali, Yassine Zakarya // GSTF Journal of Mathematics, Statistics & Operations Research;Oct2014, Vol. 2 Issue 1, p57 

    Cardiovascular diseases are the leading cause of worldwide mortality, each year more and more people die cause the cardiovascular disease comparatively to any other causes, the number of deaths because the cardiovascular disease is estimated at 17.3 million and represent 30% of the total global...

  • Recalibration of the Framingham functions to the Chinese population improved coronary heart disease risk estimates.  // ACP Journal Club;Nov/Dec2004, Vol. 141 Issue 3, p81 

    The article addresses the question how the recalibration of the Framingham functions compares with the performance of the functions derived from the Chinese Multi-provincial Cohort Study [CMCS] for determining the absolute risk for coronary heart disease (CHD) in patients without CHD. The...

  • Decline in mortality from coronary heart disease in Finland from 1969 to 1979. Salonen, Jukka T.; Puska, Pekka; Kottke, Thomas E.; Tuomilehto, Jaakko; Nissinen, Aulikki // British Medical Journal (Clinical Research Edition);6/11/1983, Vol. 286 Issue 6381, p1857 

    Examines the decline in mortality from coronary heart disease in Finland from 1969 to 1979. Comparison of the coronary mortality rate between men and women; Development of a community based cardiovascular control programme; Use of cross-county multiple regression analyses.

  • Comorbid conditions and outcomes after percutaneous coronary intervention. Singh, M.; Rihal, C. S.; Roger, V. L.; Lennon, R. J.; Spertus, J.; Jahangir, A.; Holmes Jr, D. A. // Heart;Nov2008, Vol. 94 Issue 11, p1424 

    Objective: To evaluate whether adding comorbid conditions to a risk model can help predict in-hospital outcome and long-term mortality after percutaneous coronary intervention (PCI). Design: Retrospective chart review Setting: Academic medical centre. Patients: 7659 patients who had 9032 PCIs....

  • Regional Variations and Trends in Mortality from Cardiovascular Diseases in Population aged 0-64 in Dalmatia and Slavonia, 1998-2009. Džono-Boban, Ankica; Šogorić, Selma; Vuletić, Silvije // Collegium Antropologicum;Jan2012 Supplement 1, Vol. 36, p235 

    The aim of this paper was to analyse the regional variations and trends in mortality from cardiovascular diseases in the population aged 0-64 years in Dalmatia and Slavonia, over the period 1998 to 2009. Mortality data were derived from Central Bureau of Statistics. The results show that...

  • Cardiovascular epidemiology in the Asia–Pacific region. Khor, Geok Lin // Asia Pacific Journal of Clinical Nutrition;Jun2001, Vol. 10 Issue 2, p76 

    By 2020, non-communicable diseases including cardiovascular diseases (CVD) are expected to account for seven out of every 10 deaths in the developing countries compared with less than half this value today. As a proportion of total deaths from all-causes, CVD in the Asia–Pacific region...

  • THE GROWING CHALLENGE OF CORONARY HEART DISEASE IN SOUTH ASIAIMPLICATIONS FOR THE COMMUNITY AND HEALTH SYSTEM. Bansal, Manoj Kumar // National Journal of Community Medicine;Jan-Jun2011, Vol. 2 Issue 1, p1 

    In this article, the author discusses the issues concerning the coronary heart disease in South Asia. He mentions cardiovascular diseases as the major cause of deaths and disease in the South Asian subcontinent. He further mentions of high number of cases of coronary artery disease in India that...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics